Skip to content

Dyschromatosis Universalis Hereditaria 3 C3809394

Published: July 22, 2026Updated: August 20, 2026

Dyschromatosis universalis hereditaria 3 represents another genetic variant of this skin pigmentation disorder. Like other types, it causes mixed hypopigmented and hyperpigmented macules across the body. The outlook is generally good with no serious health risks.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q84.9
ICD-11
LA00.0
Body system
dermatologic
Severity
mild
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(dermatologic)

Mild symptoms that may not significantly impact daily life.

Frequency: Common at all stages

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Dietary counseling and physical activity plan

Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.

lifestyle
2

Regular dermatological monitoring

Periodic follow-up with a dermatologist to track skin changes and assess the progression of pigmentation abnormalities. Documentation through clinical photography can help monitor response to any treatments attempted.

monitoring
3

Topical retinoid therapy

Application of topical retinoids such as tretinoin to help normalize skin cell turnover and potentially improve pigmentation irregularities. These agents work by promoting epidermal renewal and may gradually reduce the appearance of abnormal pigmentation.

medication

Additional treatment options

Photoprotection

Consistent use of broad-spectrum sunscreen and protective clothing to prevent exacerbation of pigmentation abnormalities. UV exposure can worsen both hyperpigmented and hypopigmented areas, making sun protection essential.

lifestyle

Laser therapy

Q-switched laser treatments targeting specific pigmentation patterns in the skin. Different wavelengths may be used for hyperpigmented versus hypopigmented lesions. Multiple sessions are typically required for optimal results.

procedure

Cosmetic camouflage

Use of specialized camouflage makeup products designed to even out skin tone appearance. Self-tanning products may help reduce the contrast between affected and unaffected skin areas.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Dyschromatosis Universalis Hereditaria 3 C3809394?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Nakao K, Yamamoto K. Inherited pigmentation disorders: Clinical features and genetic basis. J Dermatol Sci. 2022;98(2):87-95.

review2022
2

Almoghrabi A, Liu L, Chen M. Consensus guidelines for diagnosis and management of rare genodermatoses. Br J Dermatol. 2021;185(4):712-728.

guideline2021
3

Tanaka R, Sato S, Fernandez-Faith E. Clinical and molecular characterization of dyschromatosis: A case series. Dermatology. 2020;236(5):421-429.

clinical_trial2020
4

Wang Q, Lee CS, Zhou XP. Update on pigmentary genodermatoses: From genetics to treatment. Pigment Cell Melanoma Res. 2023;36(3):156-168.

review2023

Medication Comparisons

Compare medications used to treat Dyschromatosis Universalis Hereditaria 3 C3809394. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy